Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Thermo Fisher Scientific Inc.

Oct 2011
Thermo Fisher Scientific Inc. of Waltham, Mass., has acquired Intrinsic Bioprobes Inc. of Tempe, Ariz., to enhance its work flow for biomarker research and diagnostics. Intrinsic Bioprobes’ portfolio, including its mass spectrometric immunoassay, will enable Thermo Fisher to offer its life sciences research and clinical diagnostics customers an enhanced solution for quantitative protein biomarker detection. Intrinsic Bioprobes manufactures immuno-enrichment sample-preparation tools used in quantitative mass spectrometry.

Thermo Fisher also has completed the acquisition of Phadia of Uppsala, Sweden, a provider of blood tests for clinical diagnosis and monitoring of allergies and autoimmune diseases, adding it to its Specialty Diagnostics business.

mass spectrometry
An instrumental technique that utilizes the mass-to-charge ratio of charged particles as recorded from a mass spectrometer in order to determine the mass of a particle as well as the chemical makeup, or elemental ionic composition of a given sample or molecule.
AmericasArizonabiomarker researchBiophotonicsblood test monitoringblood tests for clinical diagnosisBusinessclinical diagnosticsdiagnosticsearnings per shareEPSEuropeIntrinsic Bioprobes sciences researchmass spectrometric immunoassaymass spectrometryMassachusettsMSIANew YorkPhadiaprotein biomarker detectionRapidScanspectroscopySwedenTest & Measurementtesting for allergies and autoimmune diseasesThermo FisherThermo Fisher Scientific Inc.Thermo Fisher Specialty Diagnostics

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!